Here are four insights:
1. During the trial, researchers randomly assigned 232 C. diff patients to receive either a frozen or fresh fecal transplantation.
2. They found that the frozen samples cured 83.5 percent of patients within 13 weeks, whereas the fresh samples cured around 85 percent in that time.
3. They also found no serious side effects with either fresh or frozen fecal transplantation.
4. The findings are published in the Journal of the American Medical Association.
More articles on GI/endoscopy:
Exact Sciences expects to double number of Cologuard tests performed, EndoChoice projects $18.6M in Q4 revenue & more –7 GI/endoscopy company key notes
GI physician leader to know: Dr. Raymond DuBois of Medical University of South Carolina
NJ Chapter of American College of Surgeons names Dr. Michael Arvanitis president: 5 takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
